These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 21406175)
1. Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis. Rau CR; Hein K; Sättler MB; Kretzschmar B; Hillgruber C; McRae BL; Diem R; Bähr M Am J Pathol; 2011 Apr; 178(4):1770-81. PubMed ID: 21406175 [TBL] [Abstract][Full Text] [Related]
2. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo. Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973 [TBL] [Abstract][Full Text] [Related]
5. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors. Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Shindler KS; Ventura E; Dutt M; Rostami A Exp Eye Res; 2008 Sep; 87(3):208-13. PubMed ID: 18653182 [TBL] [Abstract][Full Text] [Related]
7. Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation. Maier K; Merkler D; Gerber J; Taheri N; Kuhnert AV; Williams SK; Neusch C; Bähr M; Diem R Neurobiol Dis; 2007 Mar; 25(3):514-25. PubMed ID: 17239606 [TBL] [Abstract][Full Text] [Related]
8. Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. Kim HJ; Miron VE; Dukala D; Proia RL; Ludwin SK; Traka M; Antel JP; Soliven B FASEB J; 2011 May; 25(5):1509-18. PubMed ID: 21248243 [TBL] [Abstract][Full Text] [Related]
9. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies? Köhne A; Stettner M; Jangouk P; Dehmel T; Hartung HP; Lehmann HC; Kieseier BC Arch Neurol; 2012 Oct; 69(10):1280-9. PubMed ID: 22751954 [TBL] [Abstract][Full Text] [Related]
10. Fingolimod modulates microglial activation to augment markers of remyelination. Jackson SJ; Giovannoni G; Baker D J Neuroinflammation; 2011 Jul; 8():76. PubMed ID: 21729281 [TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice. Wang X; Brieland JK; Kim JH; Chen YJ; O'Neal J; O'Neil SP; Tu TW; Trinkaus K; Song SK NMR Biomed; 2013 Dec; 26(12):1742-50. PubMed ID: 23939596 [TBL] [Abstract][Full Text] [Related]
12. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Brinkmann V Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729 [TBL] [Abstract][Full Text] [Related]
13. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Foster CA; Mechtcheriakova D; Storch MK; Balatoni B; Howard LM; Bornancin F; Wlachos A; Sobanov J; Kinnunen A; Baumruker T Brain Pathol; 2009 Apr; 19(2):254-66. PubMed ID: 18540945 [TBL] [Abstract][Full Text] [Related]
14. FTY720 protects retinal ganglion cells in experimental glaucoma. You Y; Gupta VK; Li JC; Al-Adawy N; Klistorner A; Graham SL Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3060-6. PubMed ID: 24744204 [TBL] [Abstract][Full Text] [Related]